...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Novel 4-aryl-pyrido(1,2-c)pyrimidines with dual SSRI and 5-HT1A activity, part 1.
【24h】

Novel 4-aryl-pyrido(1,2-c)pyrimidines with dual SSRI and 5-HT1A activity, part 1.

机译:具有双重SSRI和5-HT1A活性的新型4-芳基-吡啶基(1,2-c)嘧啶,第1部分。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of new derivatives of 4-aryl-pyrido[1,2-c]pyrimidine containing the 3-(4-piperidyl)-1H-indole residue or its 5-methoxy derivative were synthesized. They were characterized (i) in vitro by binding to 5-HT(1A) receptors and 5-HT transporter proteins in rat brain cortex membranes and (ii) in vivo in the mouse by induced hypothermia and forced swimming models for antagonist/agonist activity against the 5-HT(1A) autoreceptors and postsynaptic 5-HT(1A) receptors, respectively. Structure activity relationship evaluation indicated that the presence of the 3-(4-piperidyl)-1H-indole residue and ortho- or para-substituents with -F or -CH(3) groups in the aryl ring as well as an unsubstituted aryl in the 4-aryl-pyrido[1,2-c]pyrimidine moiety promoted low K(i) values for both receptors. In contrast, the presence of a 5-methoxy-3-(4-piperidyl)-1H-indole residue as well as -Cl or -OCH(3) substituents at the para position markedly reduced the receptor affinity.
机译:合成了一系列含有3-(4-哌啶基)-1H-吲哚残基的4-芳基-吡啶基[1,2-c]嘧啶的新衍生物或其5-甲氧基衍生物。它们的特征是(i)在体外通过与大鼠脑皮质膜中的5-HT(1A)受体和5-HT转运蛋白结合,以及(ii)在体内通过诱导体温过低和强迫游泳模型的拮抗剂/激动剂活性在小鼠体内分别针对5-HT(1A)自身受体和突触后5-HT(1A)受体。结构活性关系评估表明,在芳基环中存在3-(4-哌啶基)-1H-吲哚残基和带有-F或-CH(3)基团的邻位或对位取代基以及未取代的芳基4-芳基-吡啶并[1,2-c]嘧啶部分促进了两个受体的低K(i)值。相反,在对位上5-甲氧基-3-(4-哌啶基)-1H-吲哚残基以及-Cl或-OCH(3)取代基的存在显着降低了受体亲和力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号